AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients
Phase 4
Completed
- Conditions
- Non Erosive Reflux DiseaseChronic Gastritis
- Interventions
- First Posted Date
- 2010-05-10
- Last Posted Date
- 2012-09-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 305
- Registration Number
- NCT01119768
- Locations
- 🇨🇳
Research Site, Shanghai, China
AZD7687 Multiple Ascending Dose Study
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 45
- Registration Number
- NCT01119352
- Locations
- 🇬🇧
Research Site, London, United Kingdom
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
Phase 2
Completed
- Conditions
- Stable Coronary Artery Disease
- Interventions
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 146
- Registration Number
- NCT01118325
- Locations
- 🇵🇭
Research Site, Quezon City, Philippines
Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT01116271
- Locations
- 🇺🇸
Reserach Site, Chapel Hill, North Carolina, United States
🇺🇸Research Site, Seattle, Washington, United States
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2010-10-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 60
- Registration Number
- NCT01116258
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2010-12-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT01116011
- Locations
- 🇯🇵
Research Site, Kanagawa, Sagamihara, Japan
Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia
Completed
- Conditions
- Valencia Autonomous RegionAsthma
- First Posted Date
- 2010-05-03
- Last Posted Date
- 2011-09-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 292
- Registration Number
- NCT01114906
- Locations
- 🇪🇸
Research Site, Valencia, Spain
AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 35
- Registration Number
- NCT01114152
- Locations
- 🇺🇸
Research Site, Glendale, California, United States
Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2013-07-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 72
- Registration Number
- NCT01112397
- Locations
- 🇺🇸
Research Site, Philadelphia, Pennsylvania, United States
Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2011-01-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 515
- Registration Number
- NCT01110564
- Locations
- 🇹🇷
Research Site, Yozgat, Turkey